Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

RiboMeth-Sequencing Reveals Selective Ribosomal RNA 2'-O-Methylation Changes in the Dorsolateral Prefrontal Cortex of Subjects With Major Depressive Disorder.

Created on 08 Nov 2026

Authors

Anuj K Verma, Bhaskar Roy, Kevin Prall, Yogesh Dwivedi

Published in

Biological psychiatry global open science. Volume 7. Issue 1. Pages 100832. Epub Sep 22, 2026.

Abstract

Major depressive disorder (MDD) is associated with widespread molecular abnormalities in the brain; however, the contribution of ribosome-centered regulatory mechanisms remains poorly understood. Ribosomal RNA (rRNA) 2'-O-methylation (Nm) is the most abundant and evolutionarily conserved RNA modification and has emerged as a determinant of ribosome heterogeneity and translational control. However, the rRNA Nm landscape has not been examined in psychiatric illness. Here, we used RiboMeth-seq to map site-specific rRNA Nm in the MDD brain.
RiboMeth-seq was performed in the dorsolateral prefrontal cortex of individuals with MDD (n = 17) and matched nonpsychiatric control subjects (n = 20) using an Illumina NextSeq2000 in 50-bp single-end mode. Specific RiboMeth-seq scores were calculated in ±2 nucleotide intervals for all RNA positions and extracted for the positions of known Nm residues in target RNA.
The overall distribution of ribose methylation scores was highly similar between groups, indicating the preservation of the global rRNA Nm landscape in MDD. At the same time, we identified 8 significantly altered Nm sites, including 4 in 28S rRNA (Am2802, Cm2848, Cm3866, and Gm4593) and 4 in 18S rRNA (Um172, Am576, Am1031, and Gm1490). These selective changes occurred in the absence of widespread remodeling, supporting a model in which MDD is associated with targeted modification of functionally relevant ribosomal positions rather than a generalized disruption of ribosome integrity.
Our findings identify rRNA Nm as a previously unrecognized layer of molecular alteration in MDD and suggest that site-specific variation in ribosome composition may contribute to aberrant translational regulation in the depressed brain.

PMID:
42999788
Bibliographic data and abstract were imported from PubMed on 08 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 15
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement